PubRank

Pharmacodynamic analyses in a multi-laboratory network: lessons from the poly(ADP-ribose) assay.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 27663481)

Published in Semin Oncol on June 15, 2016

Authors

Katherine V Ferry-Galow1, Jiuping Ji2, Robert J Kinders2, Yiping Zhang2, R Kenneth Czambel3, John C Schmitz3, Josef Herzog4, Yvonne A Evrard2, Ralph E Parchment2

Author Affiliations

1: Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD. Electronic address: Katherine.FerryGalow@nih.gov.
2: Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD.
3: University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.
4: City of Hope Beckman Research Institute, Duarte, CA.

Articles citing this ↘

Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay. PLoS One (2017) 0.75

Articles by these authors ⇆

The root causes of pharmacodynamic assay failure. Semin Oncol (2016) 0.77

Promise and limits of the CellSearch platform for evaluating pharmacodynamics in circulating tumor cells. Semin Oncol (2016) 0.75